Source link : https://www.newshealth.biz/health-news/from-fatal-to-chronic-disease/
CHICAGO — Prominent Chinese oncologist Tony Shu-Kam Mok, MD, who presented as first author of a phase 3 non–small cell lung cancer study at ASCO 2024, made a dramatic swerve in his career path at age 36. After 20 years in Canada — 7 spent practicing community oncology near Toronto — Dr Mok was visiting […]
Author : News Health
Publish date : 2024-06-21 13:17:23
Copyright for syndicated content belongs to the linked Source.
Categories